Chiasma's Total Assets for the quarter that ended in Mar. 2021 was $159.54 Mil.
During the past 12 months, Chiasma's average Total Assets Growth Rate was 496.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 140.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 52.70% per year.
During the past 8 years, Chiasma's highest 3-Year average Total Assets Growth Rate was 140.40%. The lowest was 19.60%. And the median was 33.40%.
Total Assets is connected with ROA %. Chiasma's annualizedROA % for the quarter that ended in Mar. 2021 was -72.76%. Total Assets is also linked to Revenue through Asset Turnover. Chiasma's Asset Turnover for the quarter that ended in Mar. 2021 was 0.01.
Chiasma Total Assets Historical Data
The historical data trend for Chiasma's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Chiasma's Total Assets for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Mar. 2021) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Chiasma's Asset Turnover for the quarter that ended in Mar. 2021 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Chiasma Total Assets Related Terms
Thank you for viewing the detailed overview of Chiasma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Chiasma Inc is a commercial-stage biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for rare and serious chronic disease. The US Food and Drug Administration, or the FDA, approved MYCAPSSA for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is the first and only oral somatostatin analog, or SSA, approved by the FDA and the first product approved by the FDA utilizing TPE technology. The company is focused on the commercialization of MYCAPSSA for the treatment of patients with acromegaly in the United States and developing and seeking regulatory approval of MYCAPSSA in the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHMA has been successfully added to your 